查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827391

医用塑胶市场（按应用、材料类型、工艺类型和最终用户）—2025-2032 年全球预测

Medical Plastics Market by Application, Product, Material Type, Process Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，医用塑胶市场将成长至 766.7 亿美元，复合年增长率为 9.78%。

主要市场统计数据
基准年2024年 363.3亿美元
预计2025年 398.2亿美元
预测年份：2032年 766.7亿美元
复合年增长率（%） 9.78%

简要说明医用塑胶产业现状，重点关注技术、监管环境和供应链的曲折点，以引起经营团队的关注

受快速的技术进步、监管审查力度的加强以及供应链动态的推动，医用塑胶市场正处于关键的十字路口。新材料创新、精密製造技术的进步以及对一次性使用安全性的重新关注，这些因素共同为製造商、供应商和医疗保健提供者带来了风险和机会。相关人员正在重新调整产品可靠性、生物相容性和灭菌适用性，同时寻求经济高效的途径来维持供应的连续性和法规遵循。

本执行摘要整合了应用、产品、材料、製程、最终用户和地区的关键发展，以清楚呈现近期策略要务。它综合了医院、门诊病人中心、实验室和製药商观察到的采用模式变化，并将这些变化置于射出成型、挤出和增材製造的製造选择背景下进行分析。目标是帮助领导者清晰且切实地理解如何分配工程工作、如何重组供应关係，以及法规和关税可能带来的不利影响，同时确保产品安全和性能保真度。

材料创新、精密製造、监管压力和供应链重组如何共同重新定义医用塑胶製造商的策略重点

医用塑胶产业正经历数次转型变革，这些变革共同重塑着竞争动态和业务重点。首先，微型化和功能整合的趋势正在加速精密射出成型和微流体组件的采用，迫使製造商投资于公差更高的模具和品质系统。同时，聚合物配方也在平衡灭菌耐受性和减少萃取物和可浸出物的聚合物配方转变，这使得材料选择策略更贴近最终用途检验週期。

同时，一次性和可重复使用器械组件之间的相互作用正在催生混合产品架构，这需要新的连接和灭菌方法。供应链韧性是另一个关键因素。企业正在实现供应商多元化，寻找替代树脂来源，并增加关键组件的在岸和近岸外包，以缓解物流瓶颈和地缘政治风险。最后，关于器械可追溯性和永续性的法规日益增多，正在推动对製造数据采集和可回收聚合物途径的投资。这种转变需要材料科学、製程工程和监管部门的跨职能回应，以实现更快、更安全、更具适应性的产品生命週期。

随着关税政策的变化导致采购变得更加复杂、供应风险加大，并促使企业进行生产重组，企业正在采取策略应对措施和营运调整

美国将于2025年实施新的调整后关税，将带来一系列复杂的政策，影响整个价值链的采购决策、供应商的谈判地位以及产品成本结构。虽然关税主要影响进口树脂、零件和成品组装，但其间接影响也延伸至物流规划、库存策略和长期供应商关係。製造商和采购负责人正在重新评估关税的影响，包括绘製可能受关税影响的原材料图谱、识别可免关税的类别机会，以及评估供应商迁移和关税吸收的净效益。

事实上，关税带来的成本压力正在加速关键製造流程的垂直整合和近岸外包的讨论，尤其是高价值射出成型和对设备性能至关重要的专用管路组件。采购团队也正在加强合规和关税分类工作，以避免无意的错误分类，并充分利用现有的优惠贸易待遇。在营运方面，企业正在优先考虑多方采购，为时效性强的消耗品建立紧急库存缓衝，并寻求与合作伙伴共用关税风险的合约机制。这些策略性因应措施旨在维持服务和产品供应的连续性，同时在新的贸易条件下维持可接受的利润率。

整合跨细分市场，确定产品设计选择、材料选择和製程能力需要协调的方面，以满足不同的临床和商业性需求

细分洞察揭示了应用、产品、材料、製程和最终用户维度上的差异化机会和风险状况。从应用角度来看，诊断、耗材和用品、植入、医疗设备和医疗包装各自都面临不同的工程和监管限制。在抛弃式和耗材中，导管和管材需要高弯曲性能和生物相容性；手套和手术巾需要阻隔性和触觉响应性；针头和套管需要精确的表面光洁度和抗疲劳性；注射器和药筒需要尺寸稳定性和密封完整性。诊断和监测设备强调低萃取物和光学透明度，而手术和治疗设备通常需要专门的聚合物混合物和可追溯性系统。

吹塑成型零件、薄膜、片材、射出成型产品和管材是医疗器材製造的支柱。射出成型部件，尤其是连接器和配件、外壳和壳体以及微流体组件等部件，需要严格的公差、检验的成型週期以及强大的洁净室集成，这使得供应商资格认证成为一项高要求的技术任务。聚碳酸酯因其光学透明度和抗衝击性而备受推崇，聚乙烯和聚丙烯因其化学惰性和成本效益而备受推崇，聚氯乙烯因其兼具柔韧性和加工性能而备受推崇，而硅胶则因其卓越的生物相容性和耐热性而备受青睐。每种聚合物系列在灭菌相容性、萃取行为和长期稳定性方面各有优缺点，必须与医疗器材功能性取得平衡。

製程类型细分凸显了积层製造在小批量、高复杂度零件生产中日益重要的作用，而吹塑成型、挤出、射出成型和热成型在大批量零件生产中仍然占据主导地位。积层製造方法可以实现快速迭代和无模具定制，但需要针对医疗应用进行下游检验，而传统的成型製程则提供稳定的产量和既定的认证路径。最后，最终用户细分——门诊手术中心、家庭医疗保健、医院、实验室和製药商——决定了设计优先顺序和服务水准期望。家庭医疗保健设备必须优先考虑易用性和便携性，而医院和实验室应用通常对灭菌、可追溯性和相容性有严格的要求。整合这些细分轴可以对在材料工程、製程能力和供应商伙伴关係方面的投资进行细緻的评估，以满足差异化的临床和商业性需求。

区域製造能力、管理体制和医疗保健采购行为如何影响全球市场的战术性采购和合规策略

区域动态仍然是战略规划的核心，因为美洲、欧洲、中东和非洲以及亚太地区的製造能力、法律规范和医疗保健采购行为存在显着差异。在美洲，成熟的供应链、强大的工艺专业知识基础以及来自大型医院网路的集中需求，创造了有利于大批量生产和成熟供应商伙伴关係关係的环境。在该地区营运的公司越来越注重品质系统整合和物流弹性，同时探索近岸外包以降低运输风险。

在欧洲、中东和非洲，法规的协调一致、严格的生物相容性标准以及不断推进的永续性指令正在影响材料的选择和产品的报废策略。该地区的供应商通常在可回收聚合物计划和全面环境管理系统的实施方面处于领先地位。相较之下，亚太地区是聚合物大量生产和快速扩张的中心，并拥有广泛的原料树脂、零件和售后服务供应商生态系统。利用亚太製造业的市场参与企业必须在成本优势与严格的品质保证和供应商资格监管之间取得平衡，以确保一致的合规性。因此，跨区域合作（包括多元化采购和针对特定区域的检验途径）正在成为平衡成本、合规性和连续性的最佳实践。

为什么精密製造、材料协作和供应链管治中基于能力的差异化将决定医用塑胶的竞争优势

医用塑胶生态系统的主要企业正透过对精密製造、材料科学和合规基础设施进行有针对性的投资，从而脱颖而出。一些製造商优先考虑微组件特性和先进成型技术，以抓住诊断设备和微创手术的成长机会；而另一些製造商则专注于薄膜、片材和包装创新，以满足不断发展的灭菌和阻隔性能要求。聚合物配方师和组件製造商之间的战略伙伴关係关係日益普遍，这使得能够共同开发针对特定加工窗口和灭菌方法优化的树脂等级。

组织差异化也源自于供应链管治实务。一流的公司维护严格的供应商资格认证计划、数位化追溯系统和紧急采购方案，以降低中断期间的风险。对检测实验室和生物相容性专业知识的投资支援快速提交监管文件和顺利完成审核。此外，一些公司正在探索模组化製造布局，将本地组装与分散的零件製造相结合，以更好地应对力区域需求波动。总而言之，这些公司层面的趋势凸显了从商品竞争转向以工程深度、监管应对力和弹性供应链为中心的基于能力的差异化的转变。

了解製造商和负责人可以立即采取的实用、高影响力的行动，以增强医用塑胶的弹性、加快产品开发并减少监管摩擦。

行业领导者应积极主动地将洞察转化为持久优势。首先，优先投资材料特性和灭菌验证，以加快设备整合的上市时间，并减少下游监管摩擦。其次，建构灵活的製造单元，可同时容纳微尺度射出成型和二次组装，支援结合可重复使用和一次性元件的混合产品架构。第三，创建一个多层次的供应商生态系统，包括关键树脂和组件的合格二级来源，以及正式的紧急库存策略，以缓解贸易中断和关税相关的成本波动。

此外，将数位可追溯性和品质分析功能融入生产工作流程，可实现即时决策、快速纠正措施并增强审核准备。与聚合物专家的策略合作使我们能够共同开发树脂配方，在保持可加工性的同时最大限度地减少萃取物，并与永续性蓝图保持一致，尽可能探索可回收和低碳聚合物的选择。最后，供应商选择标准可以由采购、技术和监管团队共同管理，加速供应商选择速度，同时又不影响安全性或合规性。

透明的多方法研究框架，结合专家访谈、技术标准审查和供应链压力测试，以支持以决策为中心的洞察

本分析采用了多方法研究途径，结合了专家访谈、技术文献综述和跨职能流程评估，以提供切实可行的见解。主要资讯包括与供应链负责人、产品工程师和监管专家进行的结构化讨论，从而对製程限制、材料性能权衡和区域采购行为提供定性见解。我们审查了技术文献和标准指南，以确保材料声明符合当前的灭菌和生物相容性预期，并检验了挤出、射出成型、吹塑成型、热成型和增材製造的製程能力表征。

为确保稳健性，我们的调查方法整合了比较供应商能力映射和基于情境的压力测试，这些测试假设了关税和物流中断的影响。交叉检验步骤包括将访谈观察结果与记录在案的监管决策和已发布的技术报告进行交叉核对，以及评估关键工程洞察在多个行业领域的可复製性。我们谨慎地避免专有或针对特定供应商的声明，并将分析重点放在业务影响和决策相关的权衡取舍上，而非定量的市场估算。这种方法为规划和优先排序提供了实用基础，同时保持了方法的透明度和可追溯性。

整合策略重点和能力要求，了解您的企业应如何协调工程、监管和采购决策，以实现持久的弹性

综上所述，医用塑胶产业正在经历重大的结构性调整，其驱动力来自材料创新、製造精度要求、日益严格的法规以及不断变化的贸易政策。在这种环境下，企业能否成功取决于能否整合材料科学与製程能力，加强供应商管治，并采用灵活的製造和筹资策略，以吸收政策衝击并维持产品品质。投资可灭菌聚合物、微成型专业知识和数位可追溯性的公司将更有能力满足医院、门诊中心、实验室和製药商的差异化需求。

展望未来，最具韧性的组织将是那些将细分主导的产品设计、区域製造策略和关税风险管理视为统一商业模式中相互关联组成部分的组织。这种整合的观点将加快创新週期，改善监管结果，并提高供应稳定性——所有这些都将提升病患安全性，并提高商业性绩效的可预测性。本文提出的建议旨在为领导者提供切实可行的蓝图，以帮助他们在不断变化的市场环境中协调工程、监管和采购的优先事项。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 可生物降解聚合物共混物在一次性医疗设备组件中的应用
  • 将抗菌银奈米颗粒添加剂整合到导管外壳中
  • 开发用于植入的低萃取热可塑性橡胶
  • 扩展生物相容性 PEEK 复合材料在脊椎融合和整形外科器械的应用
  • 在医疗设备包装材料中实施循环经济实践
  • 监管协调推动材料符合欧盟 MDR 和 FDA 指导方针
  • 使用 3D 列印高性能聚合物製作特定患者的手术导板
  • 用于快速原型製作和设备测试的紫外光固化医用级树脂的进展
  • 供应链数位化增强了医疗级塑胶原料的可追溯性
  • 用于医疗保健无菌阻隔包装的阻隔性聚合物薄膜

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章医用塑胶市场（按应用）

  • 诊断
  • 一次性用品和消耗品
    • 导管和管子
    • 手套和窗帘
    • 针头和套管
    • 注射器和药筒
  • 植入
  • 医疗设备
    • 诊断设备
    • 监控设备
    • 手术设备
    • 治疗设备
  • 医疗包装

第九章医用塑胶市场（按产品）

  • 吹塑成型件
  • 薄膜和片材
  • 射出成型件
    • 连接器和配件
    • 外壳和壳体
    • 微流体组件
  • 管子

第 10 章医用塑胶市场（依材料类型）

  • 聚碳酸酯
  • 聚乙烯
  • 聚丙烯
  • 聚氯乙烯
  • 硅酮

第 11 章医用塑胶市场（依工艺类型）

  • 增材製造
  • 吹塑成型
  • 挤压
  • 射出成型
  • 热成型

第 12 章医用塑胶市场（按最终用户）

  • 门诊手术中心
  • 家庭医疗保健
  • 医院
  • 研究所
  • 製药商

第十三章医用塑胶市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章医用塑胶市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国医用塑胶市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Saudi Basic Industries Corporation
    • Celanese Corporation
    • Evonik Industries AG
    • LyondellBasell Industries NV
    • Dow Inc.
    • Covestro AG
    • Eastman Chemical Company
    • Solvay SA
    • Mitsubishi Chemical Holdings Corporation
    • Sumitomo Chemical Co., Ltd.
Product Code: MRR-434CCDA04ECE

The Medical Plastics Market is projected to grow by USD 76.67 billion at a CAGR of 9.78% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 36.33 billion
Estimated Year [2025] USD 39.82 billion
Forecast Year [2032] USD 76.67 billion
CAGR (%) 9.78%

A concise orienting overview of the medical plastics landscape that highlights technological, regulatory, and supply chain inflection points demanding executive attention

The market for medical-grade plastics is at a pivotal juncture shaped by rapid technological progress, heightened regulatory scrutiny, and shifting supply chain dynamics. Emerging material innovations, advances in precision manufacturing, and a renewed focus on single-use safety profiles have converged to create both risk and opportunity for manufacturers, suppliers, and healthcare providers. Stakeholders are recalibrating around product reliability, biocompatibility, and sterilization compatibility while seeking cost-effective pathways to sustain supply continuity and regulatory compliance.

This executive summary synthesizes key developments across applications, products, materials, processes, end users, and geographies to provide a coherent view of near-term strategic imperatives. It integrates observed changes in adoption patterns among hospitals, outpatient centers, laboratories, and pharmaceutical manufacturers, and places those behaviors in the context of manufacturing choices such as injection molding, extrusion, and additive manufacturing. The goal is to equip leaders with a clear, actionable understanding of where to allocate engineering effort, how to reconfigure supply relationships, and what regulatory and tariff-driven headwinds to anticipate, all while preserving product safety and performance fidelity.

How material innovation, precision manufacturing, regulatory pressure, and supply chain reconfiguration are collectively redefining strategic priorities for medical plastics manufacturers

The landscape for medical plastics is evolving through several transformative shifts that collectively reshape competitive dynamics and operational priorities. First, the push for miniaturization and functional integration is accelerating adoption of precision injection molded components and microfluidic parts, compelling manufacturers to invest in higher tolerance tooling and quality systems. At the same time, there is a parallel migration toward polymer formulations that balance sterilization resistance with reduced extractables and leachables, driving material selection strategies closer to end-use validation cycles.

Simultaneously, the interplay between single-use disposables and reusable device components is creating hybrid product architectures that require novel joining and sterilization approaches. Supply chain resilience is another defining vector: companies are diversifying supplier bases, qualifying alternate resin sources, and increasing onshoring or nearshoring of critical components to mitigate logistics bottlenecks and geopolitical risk. Finally, increased regulatory emphasis on device traceability and sustainability considerations is prompting investments in manufacturing data capture and recyclable polymer pathways. Together these shifts demand cross-functional responses that align material science, process engineering, and regulatory affairs toward faster, safer, and more adaptable product lifecycles.

Strategic responses and operational adjustments companies are adopting as tariff policy shifts create procurement complexity, supply risk, and incentives for production realignment

The introduction of newly calibrated tariffs in the United States in 2025 presents a complex policy overlay that influences sourcing decisions, supplier negotiation posture, and product cost structures across the value chain. While tariffs primarily affect imported resins, components, and finished assemblies, the indirect consequences extend to logistics planning, inventory strategies, and long-term supplier relationships. Manufacturers and purchasers are reassessing tariff exposure by mapping bill-of-materials sensitivity, identifying tariff-exempt classification opportunities, and evaluating the net benefit of supplier relocation versus tariff absorption.

In practice, tariff-driven cost pressures are accelerating conversations about vertical integration and nearshoring of critical production steps, particularly for high-value injection molded components and specialized tubing assemblies that are core to device performance. Procurement teams are also intensifying compliance and customs classification efforts to avoid inadvertent misclassification and to take advantage of any available preferential trade treatments. From an operational perspective, companies are prioritizing multi-sourcing arrangements, establishing contingency inventory buffers for time-sensitive disposables, and pursing contractual mechanisms to share tariff risk with partners. These strategic responses aim to preserve continuity of care and product availability while maintaining acceptable margin profiles under the new trade conditions.

A cross-dimensional segmentation synthesis revealing where product design choices, material selection, and process capabilities must align to meet diverse clinical and commercial requirements

Segmentation-driven insight reveals differentiated opportunities and risk profiles across application, product, material, process, and end-user dimensions. When viewing the market through the lens of application, diagnostics, disposables and consumables, implants, medical devices, and medical packaging each exhibit distinct engineering and regulatory constraints. Within disposables and consumables, catheters and tubing demand high flexural performance and biocompatibility, gloves and drapes prioritize barrier properties and tactile responsiveness, needles and cannulas require precise surface finish and fatigue resistance, and syringes and cartridges depend on dimensional stability and seal integrity. Diagnostic and monitoring devices emphasize low extractables and optical clarity, whereas surgical and therapeutic devices often necessitate specialized polymer blends and traceability systems.

Examining products, blow molded components, films and sheets, injection molded components, and tubing form the backbone of device construction. Injection molded components in particular-encompassing connectors and fittings, housings and casings, and microfluidic components-require exacting tolerances, validated molding cycles, and robust cleanroom integration, making supplier qualification rigorously technical. Material selection acts as a fundamental differentiator: polycarbonate is prized for optical clarity and impact resistance; polyethylene and polypropylene are valued for chemical inertness and cost-efficiency; polyvinyl chloride balances flexibility with processability; and silicone provides exceptional biocompatibility and thermal resilience. Each polymer family brings trade-offs in sterilization compatibility, extraction behavior, and long-term stability that must be reconciled with device function.

Process-type segmentation highlights the growing role of additive manufacturing for low-volume, high-complexity parts and the continuing primacy of blow molding, extrusion, injection molding, and thermoforming for higher-volume components. Additive approaches enable rapid iteration and tooling-free customization but require downstream validation for medical use, while conventional molding processes deliver consistent throughput and established qualification paths. Finally, end-user segmentation-spanning ambulatory surgery centers, home healthcare, hospitals, laboratories, and pharmaceutical manufacturers-drives design priorities and service-level expectations. Devices intended for home healthcare must prioritize ease of use and transportability, whereas hospital and laboratory applications often impose stricter sterilization, traceability, and compatibility requirements. Integrating these segmentation axes enables a granular assessment of where to invest in materials engineering, process capabilities, and supplier partnerships to meet differentiated clinical and commercial needs.

How regional manufacturing capabilities, regulatory regimes, and healthcare procurement behaviors are shaping tactical sourcing and compliance strategies across global markets

Regional dynamics remain central to strategic planning, as manufacturing capacity, regulatory frameworks, and healthcare procurement behaviors vary significantly across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established supply chains, a strong base of process expertise, and concentrated demand from large hospital networks create an environment conducive to high-volume production and advanced supplier partnerships. Companies operating here increasingly focus on quality system integration and logistical resilience, while exploring nearshoring to reduce transit risk.

Across Europe, Middle East & Africa, regulatory harmonization, stringent biocompatibility standards, and progressive sustainability mandates influence material choices and product end-of-life strategies. Suppliers in this region often lead in recyclable polymer initiatives and in implementing comprehensive environmental management systems. Contrastingly, Asia-Pacific remains a hub for high-volume polymer processing capacity and rapid scaling, supported by extensive supplier ecosystems for raw resins, components, and aftermarket services. Market participants leveraging Asia-Pacific manufacturing must balance cost advantages with rigorous oversight on quality assurance and supplier qualification to ensure consistent compliance. Cross-region collaboration, including diversified sourcing and region-specific validation pathways, is therefore emerging as a best practice to reconcile cost, compliance, and continuity considerations.

Why capability-based differentiation in precision manufacturing, materials co-development, and supply chain governance determines competitive edge in medical plastics

Leading companies in the medical plastics ecosystem are distinguishing themselves through targeted investment in precision manufacturing, material science, and regulatory compliance infrastructures. Some manufacturers are prioritizing micro-component capabilities and advanced molding to capture growth in diagnostic devices and minimally invasive therapies, while others are doubling down on films, sheets, and packaging innovations to meet evolving sterilization and barrier performance requirements. Strategic partnerships between polymer formulators and component manufacturers are becoming more common, enabling co-development of resin grades optimized for specific processing windows and sterilization methods.

Organizational differentiation also stems from supply chain governance practices. Top-performing firms maintain rigorous supplier qualification programs, digital traceability systems, and contingency sourcing playbooks that reduce risk during disruptions. Investment in testing labs and biocompatibility expertise supports faster regulatory submissions and smoother audits. In addition, several companies are exploring modular manufacturing footprints that combine localized final assembly with distributed component fabrication to improve responsiveness to regional demand swings. Collectively, these company-level moves underscore a shift from commodity competition toward capability-based differentiation anchored in engineering depth, regulatory readiness, and resilient supply networks.

Practical, high-impact actions manufacturers and purchasers can take immediately to strengthen resilience, speed product development, and reduce regulatory friction in medical plastics

Industry leaders should take a proactive approach to translate insight into durable advantage. First, prioritize investments in materials characterization and sterilization validation to shorten time-to-market for device integrations and to reduce downstream regulatory friction. Second, build flexible manufacturing cells capable of handling both micro-scale injection molding and secondary assembly to support hybrid product architectures that combine reusable and single-use elements. Third, establish multi-tier supplier ecosystems that include qualified secondary sources for critical resins and components alongside formal contingency inventory strategies to mitigate trade disruptions and tariff-related cost volatility.

Additionally, embed digital traceability and quality analytics across production workflows to enable real-time decision making, faster corrective actions, and stronger audit readiness. Pursue strategic collaborations with polymer specialists to co-develop resin formulations that minimize extractables while preserving processability, and align those efforts with sustainability roadmaps that explore recyclable or lower-carbon polymer options where feasible. Finally, align commercial contracting with risk-sharing mechanisms that address tariff exposure and supply variability, and ensure procurement, engineering, and regulatory teams jointly own supplier qualification criteria to accelerate onboarding without compromising safety or compliance.

A transparent, multi-method research framework combining expert interviews, technical standards review, and supply chain stress testing to underpin decision-focused insights

This analysis is informed by a multi-method research approach that combines primary expert interviews, technical literature review, and cross-functional process assessment to produce actionable findings. Primary inputs included structured discussions with supply chain leaders, product engineers, and regulatory professionals who provided qualitative insights into process constraints, material performance trade-offs, and regional sourcing behaviors. Technical literature and standards guidance were reviewed to ensure material assertions align with current sterilization and biocompatibility expectations, and to verify process capability characterizations for extrusion, injection molding, blow molding, thermoforming, and additive manufacturing.

To ensure robustness, the methodology integrated comparative supplier capability mapping and scenario-based stress testing for tariff and logistics disruptions. Cross-validation steps included triangulating interview observations with documented regulatory decisions and published technical notes, and assessing reproducibility of key engineering insights across multiple industry segments. Care was taken to avoid proprietary or vendor-specific claims, and analytical emphasis was placed on operational implications and decision-relevant trade-offs rather than quantitative market estimates. This approach yields a pragmatic foundation for planning and prioritization while preserving methodological transparency and traceability.

A synthesis of strategic priorities and capability imperatives that frames how companies should align engineering, regulatory, and procurement decisions for lasting resilience

In sum, the medical plastics sector is navigating a period of significant structural recalibration driven by material innovation, manufacturing precision demands, regulatory intensification, and evolving trade policy. Success in this environment depends on integrating material science with process capabilities, bolstering supplier governance, and adopting flexible manufacturing and sourcing strategies that can absorb policy shocks and sustain product quality. Companies that invest in sterilization-compatible polymers, micro-molding expertise, and digital traceability will be better positioned to meet the differentiated needs of hospitals, ambulatory centers, laboratories, and pharmaceutical manufacturers.

Looking forward, the most resilient organizations will be those that treat segmentation-driven product design, regional manufacturing strategy, and tariff risk management as interconnected components of a unified operating model. That integrated perspective enables faster innovation cycles, improved regulatory outcomes, and a more stable supply posture, all of which translate into better patient safety and more predictable commercial performance. The recommendations presented here are intended to serve as an actionable roadmap for leaders who must align engineering, regulatory, and procurement priorities under evolving market conditions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of biodegradable polymer blends for single-use medical device components
  • 5.2. Integration of antimicrobial silver nanoparticle additives into catheter housings
  • 5.3. Development of low-extractable thermoplastic elastomers for implantable applications
  • 5.4. Expansion of biocompatible PEEK composites in spinal fusion and orthopedic devices
  • 5.5. Implementation of circular economy practices in medical device packaging materials
  • 5.6. Regulatory harmonization driving material compliance under EU MDR and FDA guidance
  • 5.7. Use of 3D-printed high-performance polymers for patient-specific surgical guides
  • 5.8. Advances in UV-curable medical grade resins for rapid prototyping and device testing
  • 5.9. Supply chain digitalization enhancing traceability of medical-grade plastic raw materials
  • 5.10. Adoption of high-barrier polymer films for sterile barrier packaging in healthcare

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Plastics Market, by Application

  • 8.1. Diagnostics
  • 8.2. Disposables & Consumables
    • 8.2.1. Catheters & Tubing
    • 8.2.2. Gloves & Drapes
    • 8.2.3. Needles & Cannulas
    • 8.2.4. Syringes & Cartridges
  • 8.3. Implants
  • 8.4. Medical Devices
    • 8.4.1. Diagnostic Devices
    • 8.4.2. Monitoring Devices
    • 8.4.3. Surgical Devices
    • 8.4.4. Therapeutic Devices
  • 8.5. Medical Packaging

9. Medical Plastics Market, by Product

  • 9.1. Blow Molded Components
  • 9.2. Films & Sheets
  • 9.3. Injection Molded Components
    • 9.3.1. Connectors & Fittings
    • 9.3.2. Housings & Casings
    • 9.3.3. Microfluidic Components
  • 9.4. Tubing

10. Medical Plastics Market, by Material Type

  • 10.1. Polycarbonate
  • 10.2. Polyethylene
  • 10.3. Polypropylene
  • 10.4. Polyvinyl Chloride
  • 10.5. Silicone

11. Medical Plastics Market, by Process Type

  • 11.1. Additive Manufacturing
  • 11.2. Blow Molding
  • 11.3. Extrusion
  • 11.4. Injection Molding
  • 11.5. Thermoforming

12. Medical Plastics Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Home Healthcare
  • 12.3. Hospitals
  • 12.4. Laboratories
  • 12.5. Pharmaceutical Manufacturers

13. Medical Plastics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Plastics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Plastics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Saudi Basic Industries Corporation
    • 16.3.2. Celanese Corporation
    • 16.3.3. Evonik Industries AG
    • 16.3.4. LyondellBasell Industries N.V.
    • 16.3.5. Dow Inc.
    • 16.3.6. Covestro AG
    • 16.3.7. Eastman Chemical Company
    • 16.3.8. Solvay S.A.
    • 16.3.9. Mitsubishi Chemical Holdings Corporation
    • 16.3.10. Sumitomo Chemical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. MEDICAL PLASTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MEDICAL PLASTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL PLASTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL PLASTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL PLASTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2025-2032 (